News

SCWorx Receives Nasdaq Extension to Regain Compliance

SCWorx Receives Nasdaq Extension to Regain Compliance

SCWorx Corp Secures Important Nasdaq Extension

SCWorx Corp (NASDAQ: WORX), a prominent software-as-a-service company that specializes in data management solutions for healthcare providers, has recently achieved a significant milestone by receiving a 180-day extension from Nasdaq. This extension facilitates the company's ability to comply with Nasdaq's minimum bid price requirement, paving the way for improved compliance and operational efficiencies.

Understanding the Nasdaq Extension

The extension, granted by the Listing Qualification Department of Nasdaq, gives SCWorx until a specified date to comply with Nasdaq's Rule 5550(a)(2) concerning minimum bid prices. This rule requires listed companies to maintain a minimum bid price of $1.00 for their shares. By receiving this extension, SCWorx can focus on positively impacting its stock performance.

Factors Influencing Compliance

Importantly, the company's status on the Nasdaq Capital Market remains unchanged. If the bid price for SCWorx's common stock is at or exceeds $1.00 for at least ten consecutive business days during this extended period, Nasdaq will acknowledge compliance and close the matter. Furthermore, the decision to grant the extension reflects an acknowledgment of SCWorx's overall adherence to Nasdaq's continued listing requirements aside from the bid price issue.

Mechanisms for Maintaining Listing Status

Should SCWorx fail to meet the necessary bid price by the end of the extension, it faces the possibility of delisting from the Nasdaq. In such a scenario, the company retains the right to appeal any delisting decision to a Nasdaq Hearings Panel, which would allow them to continue operating while the appeal is processed. However, success on appeal is not guaranteed, as it depends on various factors including the company's operational performance and market conditions.

About SCWorx Corp and Its Innovations

SCWorx Corp’s commitment to innovation in the healthcare data management sector is evident in its advanced solutions. The company has developed a sophisticated attributed virtualized item data warehouse that leverages machine learning and artificial intelligence. This enables SCWorx to offer a range of software-as-a-service solutions built for healthcare providers, integrating various modules to enhance operational efficiency and minimize costs.

Key Solutions Offered by SCWorx

One of the standout features of SCWorx's offerings includes their Virtual Item Master and automated rebate management modules, which streamline data management processes. Other modules include contract management, data cleansing, and automation of the Item Add Portal, ensuring that healthcare organizations benefit from precise data governance and analytics.

Impact on Healthcare Providers

The integration of SCWorx’s various solution modules promises operational efficiencies for healthcare providers. By centralizing data governance, SCWorx aids providers in making informed decisions that ultimately enhance their service delivery while adhering to budget constraints.

Frequently Asked Questions

What does the Nasdaq extension mean for SCWorx?

The extension allows SCWorx additional time to meet Nasdaq's minimum bid price requirement, helping them maintain their listing status.

What steps can SCWorx take to comply with Nasdaq requirements?

The company must ensure its stock price exceeds $1.00 for ten consecutive days during the extension period.

What happens if SCWorx fails to comply?

If compliance is not achieved, Nasdaq may initiate delisting proceedings, which SCWorx can appeal.

How does SCWorx's technology benefit healthcare providers?

SCWorx's solutions enhance data management, operational efficiencies, and cost-saving opportunities for healthcare providers.

How can I contact SCWorx for more information?

Interested parties can reach SCWorx at ir@scworx.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 863

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 742

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 150

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 200

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 245

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 597

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 238

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 286

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 151

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading

Top 5 Most Recently Viewed Articles

BetterCloud Tackles AI and SaaS Complexity with New Platform

Updated Category News Views 9

A New Era for IT Management Trying to keep tabs on the ever-growing jungle of software and AI is like herding cats these days. BetterCloud, a leader in SaaS management, just rolled out an AI-native platform to throw its hat in the ring and tackle this wild frontier. They're promising enterprises a fighting chance against the chaos with a tool that bundles AI governance,...

Continue Reading
Senvest Capital's Bold Move: New Share Buyback Plan Unveiled

Updated Category News Views 112

Senvest Capital Inc. Announces Acceptance of Buyback Program Senvest Capital Inc. (TSX: SEC) has received a green light from the Toronto Stock Exchange (TSX) to proceed with its plan for a normal course issuer bid (NCIB). The decision allows the corporation to buy back up to 100,000 of its common shares, amounting to about 4.12% of its total outstanding shares. This...

Continue Reading
Innovative Salon Chair Design Enhances Client Accessibility

Updated Category News Views 232

Revolutionizing Salon Experiences With a New Chair Design Every hairstylist knows the importance of comfort and accessibility in a salon environment. After 33 years of experience in hairstyling, one innovative stylist envisioned a solution to improve the salon chair, resulting in the development of THE SALON CHAIR. This invention enhances client safety, particularly for...

Continue Reading
Discover Magnera's Innovations at the Upcoming Conference

Updated Category News Views 167

Magnera's Participation at the 2025 Wells Fargo Conference In a notable announcement from Magnera Corporation (NYSE: MAGN), the company revealed its plans to attend the highly anticipated 2025 Wells Fargo Industrials & Materials Conference. This event is set to take place in Chicago, bringing together industry leaders and innovators from around the globe. Leadership...

Continue Reading
Walmart's Stellar Q3 Results Boosting Investor Confidence

Updated Category News Views 126

Walmart's Impressive Third-Quarter Earnings Walmart Inc. (NYSE: WMT) has once again exceeded the expectations of market analysts with a remarkable performance in its latest earnings report. The retail giant reported adjusted earnings per share of 62 cents, surpassing the market consensus of 60 cents. Initially, the stock dipped by 2.5% in response to the earnings release...

Continue Reading